Semaglutide pills: the UK's first oral GLP-1 medicine for weight loss

Step 1, taking the tablet correctly (this part matters more than it does with the injection)

The absorption-enhancer formulation that makes an oral GLP-1 possible is sensitive to what else is in your stomach. The tablet needs to be taken first thing in the morning, on a completely empty stomach, with a small sip of plain water, roughly 120ml or less. After swallowing, you wait at least 30 minutes before eating, drinking anything other than that sip of water, or taking any other oral medicine. Coffee counts. So does a mug of tea. A quick check before you start: fill a glass with about half a cup of water, set it next to your tablets the night before, and you have everything you need ready before the alarm fully registers.

This routine sounds strict, and it is, but it is also short. Thirty minutes most mornings is the trade-off for avoiding injections entirely. The tablet is swallowed whole; do not crush or split it. The NHS semaglutide medicines page carries patient-level guidance on taking semaglutide correctly, and is worth bookmarking alongside your Patient Information Leaflet.

Step 2, working through the dose schedule on the way to 25mg

Treatment begins at 1.5mg and steps up through 4mg and 9mg before reaching the 25mg maintenance dose. Each step takes at least one month, and the timing of increases is decided by your prescriber based on how you are tolerating the current dose, not by a fixed calendar. That gradual climb exists for a practical reason: most side effects are gastrointestinal, and they tend to be at their most noticeable when a dose goes up. Giving the body time at each level usually means milder, shorter-lived nausea.

People already established on the 2.4mg weekly injection may move directly to the 25mg tablet, but that step still needs clinical assessment rather than a self-managed switch. If you are wondering whether semaglutide pill treatment might suit you better than the injection you are currently using, that conversation starts with a prescriber. For a closer look at how the oral and injectable forms compare in practice, the oral semaglutide overview goes into more detail.

Step 3, what the trial evidence actually showed

The OASIS 4 trial enrolled 307 adults with obesity or overweight plus at least one weight-related condition, without diabetes, over 64 weeks. Participants on the 25mg tablet lost an average of around 13.6% of their body weight compared with around 2.4% on placebo, alongside lifestyle changes. Among those who stayed fully adherent to the regimen throughout the trial, average loss was around 17%. That second figure is the one worth framing carefully: it reflects a best-case scenario for consistent use, not the broad average.

The most commonly reported side effects in the trial were gastrointestinal (nausea, vomiting, diarrhoea, constipation) affecting around 74% of participants on the tablet versus 42% on placebo. The majority were mild to moderate and settled as the body adjusted. Semaglutide pills are not appropriate during pregnancy, while breastfeeding, or if you are trying to conceive; they are also not licensed for anyone under 18. If you want to read more about the weight-loss evidence alongside the injection's results, the weight-loss outcomes page covers both in detail.

Step 4, understanding where semaglutide pills sit in the UK licensing landscape

Wegovy tablets are licensed for weight management. Rybelsus (also oral semaglutide, but at different strengths (3mg, 7mg and 14mg)) is a separate medicine licensed for type 2 diabetes only. The two are not interchangeable, and those Rybelsus doses are not steps on the Wegovy weight-loss schedule. If you have come across references to 3mg semaglutide tablets, those relate to Rybelsus and diabetes care, not to weight management.

Wegovy tablets are not currently available on the NHS; a NICE appraisal would need to take place first. Private prescription is the only route at launch. Any legitimate private prescription for these tablets follows the same legal requirement as any other prescription-only medicine: clinical assessment by a registered prescriber comes first, every time. The over-the-counter question is one our prescribers hear regularly, the short answer is that there is no legal over-the-counter route for these medicines in the UK.

If you are weighing up the tablet against other licensed options, the treatment overview sets out what is available and how the different medicines compare. For a summary of what reviews from people using semaglutide pills have highlighted in practice, this page collects the patterns worth knowing before you start. And if you are ready to find out whether you are eligible, speaking to our prescribers is the place to begin, consultations are free, and every assessment is carried out by a GPhC-registered Independent Prescriber, not automated software.